Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
Protecting the Pediatric Skin Barrier: Expert Consensus on Environmental Triggers and Early Intervention This is a must-read article from JDD for clinicians managing pediatric skin health. Atopic dermatitis frequently begins in…
From iron oxides to depigmenting agents, how new research is changing tone correction Unlocking clear skin is a constant goal for patients, which is why hyperpigmentation research routinely tops JDD…
Hidradenitis suppurativa (HS) treatment has drastically changed in the last 15 years with FDA-approved biologics and an understanding of the need for comprehensive care that addresses the multifactorial pathogenesis of…
Addressing Estrogen Deficiency Skin Aging: A Non-Hormonal Approach Here is an insightful new study featured in the JDD! Intrinsic skin aging associated with estrogen deficiency presents a distinct therapeutic challenge…
Beyond AD and PN: Expanding Horizons for Interleukin-31 Blockade in Treatment-Refractory Pruritus Have you read this article from the JDD? Interleukin-31 receptor alpha targeting has established its place in our…
Unpacking clinical data on ingredient safety to separate viral fears from evidence-based facts Some of the most read topics in the JDD archive center on ingredient safety, and we want…